Stock Market & Financial Investment News

News Breaks September 11, 2012 08:01 EDT INSM Insmed names Will Lewis CEO and President effective immediately Lewis succeeds Tim Whitten, who resigned as President and CEO of the company. Whitten was most recently the CFO of Aegerion Pharmaceuticals. The company also appointed Donald Hayden as chairman of the board. News For INSM From The Last 14 Days Check below for free stories on INSM the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 22, 2013 10:17 EDT INSM Insmed management to meet with Lazard Capital Subscribe for More Information 06:35 EDT INSM Insmed price target raised to $22 from $13 at Leerink Subscribe for More Information May 15, 2013 10:13 EDT INSM On The Fly: Analyst Initiation Summary Subscribe for More Information 07:40 EDT INSM Insmed initiated with a Buy at Lazard Capital Subscribe for More Information May 14, 2013 08:30 EDT INSM Insmed granted key composition of matter patent allowance for Arikace in EU Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.